SIREN : 484024724
GENETEC EUROPE is a French company founded 20 years ago, specialized in the sector Conseil en systèmes et logiciels informatiques. Based in PARIS (75008), this company of category PME shows in 2024 a revenue of 33.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33 752 952 € | 31 383 774 € | 27 525 043 € | 23 577 711 € | 21 333 319 € | 18 682 609 € | 15 798 944 € | 13 800 940 € | 15 189 627 € |
| Net income | 2 977 017 € | 2 822 983 € | 3 122 782 € | 3 646 066 € | 2 611 833 € | 1 438 707 € | 1 257 153 € | 895 983 € | 1 543 451 € |
| EBITDA | 4 968 210 € | 4 730 699 € | 5 297 994 € | 6 175 972 € | 4 737 813 € | 2 725 761 € | 1 825 010 € | 1 349 373 € | 2 217 180 € |
| Net margin | 8.8% | 9.0% | 11.3% | 15.5% | 12.2% | 7.7% | 8.0% | 6.5% | 10.2% |
In 2024, GENETEC EUROPE achieves revenue of 33.8 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +10.5%. Vs 2023: +8%. After deducting consumption (0 €), gross margin stands at 33.8 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 5.0 M€, representing 14.7% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 3.0 M€, i.e. 8.8% of revenue. This profit can be retained or distributed to shareholders.
33 752 952 €
33 752 952 €
4 968 210 €
4 534 670 €
2 977 017 €
14.7%
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 71%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 10.1% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
1.066%
71.285%
10.101%
0.052
37.8%
In 2024, the debt ratio of GENETEC EUROPE (1.07) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of GENETEC EUROPE (71.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of GENETEC EUROPE (0.05) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 324.33. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.0x. Danger: operating income does not cover interest charges, unsustainable situation.
324.334
0.009
In 2024, the liquidity ratio of GENETEC EUROPE (324.33) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of GENETEC EUROPE (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 1 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 13 days. Favorable situation: supplier credit is longer than customer credit by 12 days. Overall, WCR represents 126 days of revenue, i.e. 11.9 M€ to permanently finance. Over 2016-2024, WCR increased by +671%, requiring additional financing.
11 853 699 €
1 j
13 j
0 j
126 j
Based on 215 transactions of similar company sales (all years), the value of GENETEC EUROPE is estimated at 4 929 811 € (range 2 167 743€ - 16 269 035€). With an EBITDA of 4 968 210€, the sector multiple of 1.0x is applied. The price/revenue ratio is 0.16x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare GENETEC EUROPE with other companies in the same sector:
Voir toutes les statistiques du secteur Conseil en systèmes et logiciels informatiques
The revenue of GENETEC EUROPE in 2024 is 33.8 M€.
Yes, GENETEC EUROPE generated a net profit of 3.0 M€ in 2024.
The headquarters of GENETEC EUROPE is located in PARIS (75008), in the department Paris.
The tax return of GENETEC EUROPE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
GENETEC EUROPE operates in the sector Conseil en systèmes et logiciels informatiques (NAF code 62.02A). See the 'Sector positioning' section above to compare the company with its competitors.